These results suggest Cx32 can regulate inflammatory cytokine production both in vitro and in vivo, and therefore targeting Cx32 could provide a novel treatment route to prevent atherosclerosis and other inflammatory vascular disorders [120]. The gene discussed is GJB1; the disease is atherosclerosis.